About Nagoya University Hospital

About Nagoya University Hospital


Message from the Director


Thank you for visiting the Nagoya University Hospital homepage.

Nagoya University Hospital’s history began in 1871 when it was first established as a temporary public hospital at the former site of the Nagoya Domain conference chamber. In the ensuing 140 years, with the understanding and support of the local community, it has developed into the highly-respected institution that it is today.
Currently, many patients visit our hospital from both within Aichi prefecture and elsewhere, and our hospital has a distinguished reputation for providing outstanding healthcare.
This has, however, led to excessive wait times for patients needing surgery. To resolve this issue, the Central Consultation Building B will open its doors in 2018. In addition to an ICU and operating rooms, these expanded facilities will include dedicated rooms for endoscopy, chemotherapy, and radiation therapy. These will have a huge impact on the diagnosis and treatment of cancers, and assist in better meeting patient needs by providing state-of-the-art medical care.
The new hospital building will also allow reassignment of existing facilities. This will permit us to galvanize our pediatric care program, an initiative we hold vital as a Childhood cancer hub hospital. Eventually, we hope to establish a pediatric medical center by collaboration with the Center for Maternal - Neonatal Care, allowing for complete healthcare coverage from prenatal diagnosis to the immediate postnatal period, and further extending into adult care, thus ensuring advanced medical treatment for the entirety of a patient's lifetime.

In December 2016, we were designated the first medical institution in Central Japan to perform cardiac transplantations based on recognition of our success in treating patients with heart failure. As the last bastion of hope in severe heart failure, we will strive to support those patients awaiting cardiac transplantation. Our goal is to become even more actively involved in transplantation medicine.
Our facility is also one of the Core Clinical Research Hospitals that lead development of new drugs and new medical technologies from within Japan. There are still many diseases around that world where no treatment is available. In Central Consultation Building B, we will establish beds where first-in-human studies will be conducted in Japan before anywhere else in the world, allowing us to develop new medical treatments to meet patient needs. Moreover, Core Clinical Research Hospitals also fulfill the role of facilities that offer patient-requested recuperation treatment. If the patient requests this type of treatment, then our facility is able to provide them with therapies and drugs that are yet to be approved in Japan, expanding potential treatment choices. To cure diseases that were previously incurable, we have a responsibility to move forward with first-in-Japan or first-in-the-world treatment initiatives.

In the future, we hope to work towards globalization of medical care. Although we are already expanding internationally, especially within Asia, we must become internationally ubiquitous as "Meidai Hospital" where patients will come from around the world. To achieve this goal, we must prove that our quality of medical care and assurance of patient safety meets the international standards of care. We are currently preparing for an evaluation from the Joint Commission International(JCI), in order to gain accreditation. If we are accredited, then it will be easier to receive approval for drug development, and this will provide us with a foothold towards further advances in medical care.
However, hospitals are no exception to the manpower shortage that plagues Japanese society today. Starting with the introduction of a transport robot to take on night-time delivery duties, we hope to move forward with an IoT of the hospital. In the future, as our goal, we will network hospital medical devices and patient data to enhance improvement in healthcare and the quality of safety measures.
By providing patients with more advanced and safer medical treatment, our hospital aims to continue making progress in healthcare.

We appreciate your continued support and encouragement.

Naoki ISHIGURO, M.D., Ph.D.
Director, Nagoya University Hospital

As of July 1st, 2017